首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1882篇
  免费   101篇
  国内免费   45篇
耳鼻咽喉   9篇
儿科学   6篇
妇产科学   2篇
基础医学   48篇
口腔科学   111篇
临床医学   139篇
内科学   940篇
皮肤病学   2篇
神经病学   109篇
特种医学   86篇
外科学   342篇
综合类   163篇
现状与发展   1篇
预防医学   19篇
眼科学   1篇
药学   34篇
  1篇
中国医学   13篇
肿瘤学   2篇
  2024年   2篇
  2023年   45篇
  2022年   73篇
  2021年   114篇
  2020年   130篇
  2019年   98篇
  2018年   128篇
  2017年   47篇
  2016年   61篇
  2015年   81篇
  2014年   123篇
  2013年   135篇
  2012年   76篇
  2011年   86篇
  2010年   65篇
  2009年   71篇
  2008年   76篇
  2007年   76篇
  2006年   53篇
  2005年   43篇
  2004年   57篇
  2003年   47篇
  2002年   46篇
  2001年   45篇
  2000年   37篇
  1999年   28篇
  1998年   30篇
  1997年   30篇
  1996年   14篇
  1995年   10篇
  1994年   6篇
  1993年   10篇
  1992年   12篇
  1991年   15篇
  1990年   9篇
  1989年   2篇
  1988年   8篇
  1987年   5篇
  1986年   3篇
  1985年   6篇
  1984年   5篇
  1983年   4篇
  1982年   6篇
  1981年   8篇
  1977年   1篇
  1976年   1篇
排序方式: 共有2028条查询结果,搜索用时 31 毫秒
21.
22.
叶玲 《口腔医学》2016,(11):961-967
再生性牙髓治疗是基于生物学基础治疗的一种方法,目的是替换受损的部分牙髓组织或允许牙髓样组织形成以完全替代原牙髓组织。针对牙髓炎或牙髓坏死的年轻恒牙的治疗,研究者们利用口腔来源干细胞或根尖周组织的干细胞建立各种利于修复的微环境,提出了如牙髓血运重建术/干细胞归巢治疗等充满前景的新治疗技术,从而为牙髓的再生提供了大量研究资料及可选治疗手段。该文对再生性牙髓治疗方法的现状及其发展前景作一综述。  相似文献   
23.
24.
25.
26.
27.
28.
BackgroundLong-term cardiovascular and limb outcomes after revascularization for peripheral artery disease and, in particular, prognosis after post-procedure major adverse limb events (MALE) are not well-studied.ObjectivesThis study sought to describe outcomes after peripheral revascularization and assess relationships between post-procedure MALE hospitalization and subsequent events.MethodsPatients undergoing peripheral artery revascularization between January 1, 2009, and September 30, 2015, in the Premier Healthcare Database were examined for the co-primary outcomes of interest, composite myocardial infarction (MI) or stroke and composite major amputation or peripheral revascularization. Multivariable adjusted Cox proportional hazards models with post-procedure MALE hospitalization included as a time-dependent covariate were developed to estimate hazard ratios for outcomes.ResultsAmong 393,017 revascularized patients followed for a median of 2.7 years (interquartile range: 1.3 to 4.4 years), the cumulative incidence of MI or stroke was 9.8% and that of major amputation or peripheral revascularization was 41.9%. A total of 50,750 patients (12.9%) had at least 1 post-procedure MALE hospitalization. In time-dependent covariate adjusted models, post-procedure MALE hospitalization was associated with greater risk of subsequent MI or stroke (hazard ratio: 1.34; 95% confidence interval: 1.28 to 1.40) and major amputation or peripheral revascularization (hazard ratio: 8.13; 95% confidence interval: 7.96 to 8.29). After peripheral revascularization with or without post-procedure MALE hospitalization, risk of limb events increased rapidly post-procedure and more slowly after the first year, whereas cardiac risk increased steadily during follow-up.ConclusionsRevascularized peripheral artery disease patients face earlier limb and later cardiovascular ischemic risk that is heightened among patients with post-procedure MALE hospitalization. Increased provider awareness of these long-term risks may guide efforts to improve post-procedural outcomes.  相似文献   
29.

Objective

The frailty index has been linked to adverse outcomes after surgical procedures. In this study, we evaluated the association between frailty index and outcomes after elective lower extremity bypass (LEB) for lower extremity ischemia.

Methods

The American College of Surgeons National Surgical Quality Improvement Program data set (2005-2012) was used to identify patients who underwent elective LEB using diagnostic and procedure Current Procedural Terminology codes. Modified frailty index (mFI) scores, derived from the Canadian Study of Health and Aging, were categorized into three groups: low, medium, and high. Association of mFI with 30-day postoperative death (POD), myocardial infarction (MI), cardiopulmonary events (CPEs), deep tissue surgical site infection (SSI), and graft failure (GF) was evaluated. Both univariate and multivariable regression analyses—adjusted for age, sex, American Society of Anesthesiologists class, body mass index, and creatinine levels—were used to assess the effect of frailty on each outcome.

Results

Of 12,677 patients (mean age, 67.7 ± 11.1 years) identified who underwent elective LEB, POD occurred in 265 (2.1% overall). Postoperative MI, SSI, CPEs, and GF occurred in 1.6%, 2.5%, 3.1%, and 4.3%, respectively. The mean mFI of the entire sample was 0.3 ± 0.1. Adjusted odds ratio for development of any morbidity in the group with the highest mFI was 1.36 (95% confidence interval, 1.08-1.72; P = .010) compared with the low frailty group. Patients with higher mFI were more likely to develop MI and CPEs but not SSI or GF. Univariate and multivariable analyses showed a significantly increased risk of POD among those in the highest mFI tertile. Female sex and age, increased American Society of Anesthesiologists class and creatinine levels, and decreased body mass index independently predicted increased mortality. The addition of categorical mFI improved models with these variables.

Conclusions

Higher mFI is independently associated with higher mortality and morbidity. Preoperative mFI assessment may be considered an additional screening tool for risk stratification among patients undergoing LEB.  相似文献   
30.

Objective

To evaluate the cost-effectiveness of using drugeluting stents (DES) compared to bare-metal stents (BMS) for coronary heart disease (CHD).

Data sources/study setting

Data were obtained from the National Health Insurance Longitudinal Health Insurance Database, which contains claims data for 1,000,000 beneficiaries. The data were randomly sampled from all beneficiaries.

Study design

A retrospective claims data analysis.

Data collection/extraction methods

Patients with stable coronary heart disease who underwent coronary stent implantation from 2007 to 2008 were recruited and followed to the end of 2013. After a 2:1 propensity score matched by gender, age, stent number, and the Charlson comorbidity index (CCI), 852 patients with 568 stents in the BMS group and 284 stents in the DES group were included. The cumulative medical costs for both matched groups were estimated with the Kaplan-Meier Sample Average (KMSA), and then the incremental cost-effectiveness ratio (ICER) was estimated.

Principal findings

The ICER of DES vs. BMS was NT$ 663,000 per cardiovascular death averted and NT$ 238,394 per cardiovascular death or coronary event averted in five years from the insurer perspective.

Conclusion

Percutaneous coronary intervention (PCI) with DES was a more cost-effective strategy than PCI with BMS for CHD patients during the five-year follow-up.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号